Current management of sinusoidal portal hypertension

American Surgeon

Volumn 74, Issue 1, 2008, Pages 4-10

  Ravindra, Kadiyala V ^a   Eng, Mary ^a   Marvin, Michael ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR 7; GLYCERYL TRINITRATE; HYPERTENSIVE FACTOR; NADOLOL; OCTREOTIDE; POLIDOCANOL; PROPRANOLOL; SOMATOSTATIN; TERLIPRESSIN; TETRADECYL SULFATE SODIUM; VASOPRESSIN;

ASCITES; BRAIN DISEASE; CRITICALLY ILL PATIENT; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC SURGERY; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; GASTROINTESTINAL HEMORRHAGE; HEPATOPULMONARY SYNDROME; HEPATORENAL SYNDROME; HUMAN; HYPERSPLENISM; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER TRANSPLANTATION; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PORTOPULMONARY HYPERTENSION; RECURRENT DISEASE; SURGEON; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; BALLOON DILATATION; ENDOSCOPY; PATHOLOGY; PORTOSYSTEMIC ANASTOMOSIS; REVIEW;

BALLOON DILATATION; ENDOSCOPY; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PORTASYSTEMIC SHUNT, SURGICAL;

EID: 40749121761     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (49)

1. Schweisinger WH, Page CP, Sirinek KR, et al. Operations for peptic ulcer disease: Paradigm lost. J Gastrointest Surg 2001;5:438-43.
2. Klupp J, Kohler S, Pascher A, Neuhaus P. Liver transplantation as ultimate tool to treat portal hypertension. Dig Dis 2005;23:65-71.
3. Henderson JM, Yang Y. Is there still a role for surgery in bleeding portal hypertension? Nature Clinical Practice 2005;2:246-7.
4. Bosch J, D'Amico G, Garcia-Pagan JC. Portal hypertension. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's Diseases of the Liver, 9th ed. Philadelphia: Lippincott Williams & Wilkins, 2003.
5. Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology 2004;39:476-83.
6. Boyer TD, Triger DR, Horisawa M, et al. Direct transhepatic measurement of portal vein pressure using a thin needle. Comparison with wedged hepatic venous pressure. Gastroenterology 1977;72:584-9.
7. Rector WG Jr, Redeker AG. Direct transhepatic assessment of hepatic vein pressure and direction of flow using a thin needle in patients with cirrhosis and Budd-Chiari syndrome. An effective alternative hepatic vein catheterization. Gastroenterology 1984;86:1395-9.
8. Keiding S, Solvig J, Gronbaek H, Vilstrup H. Combined liver vein and spleen pulp pressure measurements in patients with portal or splenic vein thrombosis. Scand J Gastroenterol 2004;39:594-9.
9. Myers JD, Taylor WJ. An estimation of portal pressure by occlusive catheterization of a hepatic venule. J Clin Invest 1951;30:662-3.
10. Villanueva C, Lopez-Balaguer JM, Aracil C, et al. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis. J Hepatol 2005;40:757-65.
11. Bruix J, Castells A, Bosch J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure. Gastroenterology 1996;111:1018-22.
12. Songcharatrawee S, Groszmann RJ. Diagnosing portal hypertension. Baillieres Clin Gastroenterol 2000;14:881-94.
13. Wind P, Alves A, Chevallier JM, et al. Anatomy of spontaneous splenorenal and gastrorenal venous anastomoses - Review of literature. Surg Radiol Anat 1998;20:129-34.
14. Hsieh J, Wang J, Huang C, et al. Effect of spontaneous portosystemic shunts on hemorrhage from esophagogastric varices. World J Surg 2004;28:23-8.
15. Schepis F, Camma C, Niceforo D, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology 2001;33:333-8.
16. D'Amico G, Luca A. Natural history. Clinical-hemodynamic correlations. Prediction of the risk of bleeding. Baillieres Clin Gastroenterol 1997;11:243-56.
17. D'Amico G. The Clinical course of portal hypertension in liver cirrhosis. In: Rossi P, ed. Diagnostic Imaging and Imaging Guided Therapy. Berlin: Springer-Verlag, 2000:15-24.
18. El Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veteran Affairs. Am J Gastroenterol 2000;95:3566-73.
19. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: An evidence-based approach. Semin Liver Dis 1999;19:475-505.
20. D'Amico G, Garcia-Tsao G, Cales P, et al. Diagnosis of portal hypertension. How and when? In: De Franchis R, ed. Portal Hypertension III. Proceedings of the Third Baverno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Oxford: Blackwell Science, 2001:36-63.
21. De Franchis R. Evolving consensus in portal hypertension. Report of the Baverno IV Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension. J Hepatol 2005;43:167-76.
22. Pagliaro L, D'Amico G, Sorensen TI, et al. Prevention of first bleeding in cirrhotics. A metaanalysis of randomized trials of nonsurgical treatment. Ann Intern Med 1992;117:59-70.
23. Ejlersem E, Meisen T, Ingerslev J, et al. Recombinant activated factor VII acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices. Scand J Gastroenterol 2001;36:1081-5.
24. Ioannou G, Doust J, Rockey DC. Terlipressin for acute esophageal variceal hemorrhage (Cochrane review). Cochrane Database Syst Rev 2001;1:CD002147.
25. Wright AS, Rikkers LF. Current management of portal hypertension. J Gastrointest Surg 2005;9:992-1005.
26. De Franchis R, Primignani M. Endoscopic treatments for portal hypertension. Semin Liver Dis 1999;19:439-55.
27. Burroughs AK, Patch D. Transjugular intrahepatic portosystemic shunt. Semin Liver Dis 1999;19:457-73.
28. Orloff MJ, Orloff MS, Orloff SL, et al. Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver. J Am Coll Surg 1995;180:257-72.
29. Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet 2003;361:952-4.
30. De Franchis R. Updating consensus in portal hypertension: report of the third Baveno consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000;31:1061-7.
31. Henderson JM, Yang Y. Is there still a role for surgery in bleeding portal hypertension? Nat Clin Pract Gastroenterol Hepatol 2005;2:246-7.
32. Warren WD. Presidential address: Reflections on the early development of portacaval shunts. Ann Surg 1980;191:519-27.
33. Whipple AO. The problem of portal hypertension in relation to the hepatosplenopathies. Ann Surg 1945;122:449.
34. Warren WD, Zeppa R, Fomon JJ. Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg 1967;166:437-55.
35. Henderson JM, Millikan WJ Jr, Wright-Bacon L, et al. Hemodynamic differences between alcoholic and nonalcoholic cirrhotics following distal splenorenal shunt - Effect on survival? Ann Surg 1983;198:325-34.
36. Inokuchi K, Kobayashi M, Kusaba A, et al. New selective decompression of esophageal varices. By a left gastric venous-caval shunt. Arch Surg 1970;100:157-62.
37. Bismuth H, Houssin D, Grange D. Suppression of the shunt and esophageal transaction. A new technique for the treatment of disabling postshunt encephalopathy. Am J Surg 1983;146:392-6.
38. Sarfeh IJ, Rypins EB, Conroy RM, Mason GR. Portal H-Graft: Relationship of shunt diameter, portal flow patterns and encephalopathy. Ann Surg 1983;197:422-6.
39. Knechtle SJ, Kalayoglu M, D'Alessandro AM, et al. Portal hypertension: Surgical management in the 1990s. Surgery 1994;116:687-95.
40. Knechtle SJ. Portal hypertension: From Eck's fistula to TIPS. Ann Surg 2003;238:S49-55.
41. Elwood DR, Pomposelli MD, Pomfret EA, et al. Distal splenorenal shunt - Preferred treatment for recurrent variceal hemorrhage in the patient with well-compensated cirrhosis. Arch Surg 2006;141:385-8.
42. Rosemurgy AS, Serafini F, Zweibel BR, et al. Transjugular intrahepatic portosystemic shunt vs small diameter prosthetic H-graft portacaval shunt: extended follow-up of an expanded randomized trial. J Gastrointest Surg 2000;4:589-97.
43. Henderson JM, Yang Y. Is there a role for surgery in portal hypertension? Nature Clinical Practice Gastroenterology & Hepatology 2005;2:246-7.
44. Sugiura M, Futagawa S. Results of six hundred thirty-six esophageal transactions with paraesophagogastric devascularization in the treatment of esophageal varices. J Vasc Surg 1984;1:254-60.
45. Hassab M. Gastro-esophageal decongestion and splenectomy GEDS (Hassab), in the management of bleeding varices. Review of literature. Int Surg 1998;83:38-41.
46. Romero-Torres R. Hemostatic suture of the stomach for the treatment of massive hemorrhage due to esophageal varices. Surg Gynecol Obstet 1981;153:710-2.
47. Rossle M, Richter GM, Noldge G, et al. Performance of an intrahepatic portacaval shunt (PCS) using a catheter technique - A case report. Hematology (Am Soc Hematol Educ Program) 1988;8:1348A.
48. Andreas Ochs. Tran jugular intrahepatic portosystemic shunt. Dig Dis 2005;23:56-64.
49. Kamath PS, Kim WR. The Model for End-stage Liver disease (MELD). Hepatology 2007;45:707-805.